It is classified as a research chemical, meaning: It cannot be legally marketed as a drug or supplement It is not recognized as "Generally Recognized as Safe" (GRAS) No New Drug Application (NDA) has been submitted It has not undergone the formal FDA approval process Research Chemical Status BPC-157 is available for purchase as a "research chemical" in most jurisdictions, with important caveats: Sold for "research purposes only" Not for human consumption (legally) No quality standards enforced by regulatory agencies Purity and identity depend entirely on supplier integrity International Regulations Regulatory status varies by country: United States : Research chemical, not approved for human use European Union : Not approved, status varies by member state Canada : Not approved for human use, research chemical Australia : Not approved, TGA Category 4 substance United Kingdom : Not approved for human use Sports and Competition BPC-157 is not specifically listed on the World Anti-Doping Agency (WADA) prohibited list, unlike TB-500

A structured discontinuation plan should include strategies for maintaining glycemic control and weight management, such as initiating alternative medications, intensifying lifestyle modifications, and scheduling appropriate follow-up appointments
Semaglutide vs Metformin : While metformin is often used as the first-line treatment, semaglutide may be more beneficial for patients who also need help with weight management, as semaglutide has been shown to aid in weight loss
This is a good dupe of my all time fave Australian Vitamin E Skin Repair Cream
Gastrointestinal studies have shown that orally administered BPC-157 exerts cytoprotective effects throughout the digestive tract, including protection against NSAID-induced gastric lesions, alcohol-induced mucosal damage, and stress-induced intestinal barrier dysfunction